These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24820861)

  • 1. Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy.
    Ruiz Ramos J; Roma E; Palomar L; Poveda JL
    Chemotherapy; 2013; 59(5):344-5. PubMed ID: 24820861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer.
    Méndez LE; Mueller A; Salom E; González-Quintero VH
    Obstet Gynecol; 2003 Nov; 102(5 Pt 2):1200-2. PubMed ID: 14607056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma.
    Hubalek M; Smekal-Schindelwig C; Zeimet AG; Sergi C; Brezinka C; Mueller-Holzner E; Marth C
    Arch Gynecol Obstet; 2007 Aug; 276(2):179-83. PubMed ID: 17342499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined chemotherapy with paclitaxel and carboplatin for mucinous cystadenocarcinoma of the ovary during pregnancy.
    Doi D; Boh Y; Konishi H; Asakura H; Takeshita T
    Arch Gynecol Obstet; 2009 Oct; 280(4):633-6. PubMed ID: 19205713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
    Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
    Pignata S; Scambia G; Katsaros D; Gallo C; Pujade-Lauraine E; De Placido S; Bologna A; Weber B; Raspagliesi F; Panici PB; Cormio G; Sorio R; Cavazzini MG; Ferrandina G; Breda E; Murgia V; Sacco C; Cinieri S; Salutari V; Ricci C; Pisano C; Greggi S; Lauria R; Lorusso D; Marchetti C; Selvaggi L; Signoriello S; Piccirillo MC; Di Maio M; Perrone F; ; ; ; ;
    Lancet Oncol; 2014 Apr; 15(4):396-405. PubMed ID: 24582486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.
    Sood AK; Shahin MS; Sorosky JI
    Gynecol Oncol; 2001 Dec; 83(3):599-600. PubMed ID: 11733979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
    Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
    Bamias A; Papadimitriou C; Efstathiou E; Rodolakis A; Vlahos G; Voulgaris Z; Bozas G; Fountzilas G; Aravantinos G; Razis E; Gika D; Dimopoulos MA
    BMC Cancer; 2006 Sep; 6():228. PubMed ID: 16999858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer in pregnancy.
    Fruscio R; de Haan J; Van Calsteren K; Verheecke M; Mhallem M; Amant F
    Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():108-117. PubMed ID: 28029502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review.
    Karimi Zarchi M; Behtash N; Modares Gilani M
    Arch Gynecol Obstet; 2008 Jan; 277(1):75-8. PubMed ID: 17653741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
    Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T
    Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review.
    Picone O; Lhommé C; Tournaire M; Pautier P; Camatte S; Vacher-Lavenue MC; Castaigne D; Morice P
    Gynecol Oncol; 2004 Aug; 94(2):600-4. PubMed ID: 15297214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review.
    Ferrandina G; Distefano M; Testa A; De Vincenzo R; Scambia G
    Gynecol Oncol; 2005 May; 97(2):693-6. PubMed ID: 15863184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial.
    Potamianou A; Androulakis N; Papakotoulas P; Toufexi H; Latoufis C; Kouroussis C; Christofilakis C; Xenidis N; Georgoulias V; Polyzos A
    Oncology; 2005; 69(4):348-53. PubMed ID: 16293974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcome.
    Bamias A; Bamia C; Karadimou A; Soupos N; Zagouri F; Rodolakis A; Haidopoulos D; Vlahos G; Thomakos N; Antsaklis A; Dimopoulos MA
    Oncology; 2011; 81(5-6):365-71. PubMed ID: 22248920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy.
    Seamon LG; Downey GO; Harrison CR; Doss B; Carlson JW
    Gynecol Oncol; 2009 Sep; 114(3):540-1. PubMed ID: 19523669
    [No Abstract]   [Full Text] [Related]  

  • 19. Three-hour paclitaxel infusion and carboplatin is an effective outpatient treatment for stage III epithelial ovarian cancer.
    Brown JV; Rettenmaier MA; Dillman RA; Birk CL; Culkin K; Micha JP
    Gynecol Oncol; 1998 Feb; 68(2):166-8. PubMed ID: 9514805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin and short-infusion paclitaxel in high-risk and advanced-stage ovarian carcinoma.
    Coleman RL; Bagnell KG; Townley PM
    Cancer J Sci Am; 1997; 3(4):246-53. PubMed ID: 9263631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.